Search research articles
Contact Us
Filters
Showing results (51-60 of 260) with videos related to
Page
of 26
Sort By:
Nature
|
September 9, 2020
How we learnt to stop worrying and love web scraping
Nicholas J DeVito, Georgia C Richards, Peter Inglesby
Archives of Toxicology
|
January 23, 2025
A physiologically based pharmacokinetic (PBPK) model describing the kinetics of a commercial mixture α-, β-, and γ-hexabromocyclododecane exposure in mice
Claude Emond, Michael J DeVito, Linda S Birnbaum
BMJ (Clinical Research Ed.)
|
November 23, 2019
Why researchers should share their analytic code
Ben Goldacre, Caroline E Morton, Nicholas J DeVito
The American Journal of Bioethics : AJOB
|
May 25, 2017
Bringing Transparency to Medicine: Exploring Physicians' Views and Experiences of the Sunshine Act
Susan Chimonas, Nicholas J DeVito, David J Rothman
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
April 2, 2004
Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat
Claude Emond, Linda S Birnbaum, Michael J DeVito
Occupational Health & Safety (Waco, Tex.)
|
March 1, 1985
Even 'healthy' environments can harbor many hidden hazards
W N Christenson, C F Brennan, J DeVito
Evidence-Based Dentistry
|
October 27, 2018
Too few trials or too few reported trials?
Andrés Viteri-García, Nicholas J DeVito, Ben Goldacre
Developmental Psychobiology
|
September 1, 1981
Developmental aspects of 2-way shuttlebox avoidance in the spontaneously hypertensive and normotensive rat
J R Sutterer, W J DeVito, I Rykaszewski
Endocrinology
|
December 1, 1982
Increased secretion of vasopressin and adenosine 3',5'-monophosphate from hypothalamic-posterior pituitary units of spontaneously hypertensive rats
W J DeVito, M Miller, J R Sutterer
Toxicology and Applied Pharmacology
|
August 14, 2021
A PBPK model describing the pharmacokinetics of γ-HBCD exposure in mice
Claude Emond, Michael J DeVito, Linda S Birnbaum
Page
of 26
Search research articles
Search
Showing results (51-60 of 260) with videos related to
Sort By:
Page
of 26
Nature
|
September 9, 2020
How we learnt to stop worrying and love web scraping
Nicholas J DeVito, Georgia C Richards, Peter Inglesby
Archives of Toxicology
|
January 23, 2025
A physiologically based pharmacokinetic (PBPK) model describing the kinetics of a commercial mixture α-, β-, and γ-hexabromocyclododecane exposure in mice
Claude Emond, Michael J DeVito, Linda S Birnbaum
BMJ (Clinical Research Ed.)
|
November 23, 2019
Why researchers should share their analytic code
Ben Goldacre, Caroline E Morton, Nicholas J DeVito
The American Journal of Bioethics : AJOB
|
May 25, 2017
Bringing Transparency to Medicine: Exploring Physicians' Views and Experiences of the Sunshine Act
Susan Chimonas, Nicholas J DeVito, David J Rothman
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
April 2, 2004
Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat
Claude Emond, Linda S Birnbaum, Michael J DeVito
Occupational Health & Safety (Waco, Tex.)
|
March 1, 1985
Even 'healthy' environments can harbor many hidden hazards
W N Christenson, C F Brennan, J DeVito
Evidence-Based Dentistry
|
October 27, 2018
Too few trials or too few reported trials?
Andrés Viteri-García, Nicholas J DeVito, Ben Goldacre
Developmental Psychobiology
|
September 1, 1981
Developmental aspects of 2-way shuttlebox avoidance in the spontaneously hypertensive and normotensive rat
J R Sutterer, W J DeVito, I Rykaszewski
Endocrinology
|
December 1, 1982
Increased secretion of vasopressin and adenosine 3',5'-monophosphate from hypothalamic-posterior pituitary units of spontaneously hypertensive rats
W J DeVito, M Miller, J R Sutterer
Toxicology and Applied Pharmacology
|
August 14, 2021
A PBPK model describing the pharmacokinetics of γ-HBCD exposure in mice
Claude Emond, Michael J DeVito, Linda S Birnbaum
Page
of 26